314 related articles for article (PubMed ID: 21685203)
1. Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells.
Lemonnier T; Blanchard S; Toli D; Roy E; Bigou S; Froissart R; Rouvet I; Vitry S; Heard JM; Bohl D
Hum Mol Genet; 2011 Sep; 20(18):3653-66. PubMed ID: 21685203
[TBL] [Abstract][Full Text] [Related]
2. Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B.
Li HH; Zhao HZ; Neufeld EF; Cai Y; Gómez-Pinilla F
J Neurosci Res; 2002 Jul; 69(1):30-8. PubMed ID: 12111813
[TBL] [Abstract][Full Text] [Related]
3. GM130 gain-of-function induces cell pathology in a model of lysosomal storage disease.
Roy E; Bruyère J; Flamant P; Bigou S; Ausseil J; Vitry S; Heard JM
Hum Mol Genet; 2012 Apr; 21(7):1481-95. PubMed ID: 22156940
[TBL] [Abstract][Full Text] [Related]
4. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
Huang W; Cheng YS; Yang S; Swaroop M; Xu M; Huang W; Zheng W
Exp Cell Res; 2021 Oct; 407(1):112785. PubMed ID: 34411609
[TBL] [Abstract][Full Text] [Related]
5. Enhanced degradation of synaptophysin by the proteasome in mucopolysaccharidosis type IIIB.
Vitry S; Ausseil J; Hocquemiller M; Bigou S; Dos Santos Coura R; Heard JM
Mol Cell Neurosci; 2009 May; 41(1):8-18. PubMed ID: 19386237
[TBL] [Abstract][Full Text] [Related]
6. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
Yogalingam G; Hopwood JJ
Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
[TBL] [Abstract][Full Text] [Related]
8. Directed differentiation and characterization of genetically modified embryonic stem cells for therapy.
Lau AA; Hemsley KM; Meedeniya A; Robinson AJ; Hopwood JJ
Methods Mol Biol; 2006; 329():471-84. PubMed ID: 16846011
[TBL] [Abstract][Full Text] [Related]
9. GAP43 overexpression and enhanced neurite outgrowth in mucopolysaccharidosis type IIIB cortical neuron cultures.
Hocquemiller M; Vitry S; Bigou S; Bruyère J; Ausseil J; Heard JM
J Neurosci Res; 2010 Jan; 88(1):202-13. PubMed ID: 19658197
[TBL] [Abstract][Full Text] [Related]
10. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB.
Zheng Y; Ryazantsev S; Ohmi K; Zhao HZ; Rozengurt N; Kohn DB; Neufeld EF
Mol Genet Metab; 2004 Aug; 82(4):286-95. PubMed ID: 15308126
[TBL] [Abstract][Full Text] [Related]
11. Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II.
Rybová J; Ledvinová J; Sikora J; Kuchař L; Dobrovolný R
J Inherit Metab Dis; 2018 Mar; 41(2):221-229. PubMed ID: 29168031
[TBL] [Abstract][Full Text] [Related]
12. An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene.
Huang W; Xu M; Li R; Baskfield A; Kouznetsova J; Beers J; Zou J; Liu C; Zheng W
Stem Cell Res; 2019 May; 37():101427. PubMed ID: 30933722
[TBL] [Abstract][Full Text] [Related]
13. Novel extracellular matrix structures in the neural stem cell niche capture the neurogenic factor fibroblast growth factor 2 from the extracellular milieu.
Kerever A; Schnack J; Vellinga D; Ichikawa N; Moon C; Arikawa-Hirasawa E; Efird JT; Mercier F
Stem Cells; 2007 Sep; 25(9):2146-57. PubMed ID: 17569787
[TBL] [Abstract][Full Text] [Related]
14. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
Li F; Bronson S; Niyibizi C
J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
[TBL] [Abstract][Full Text] [Related]
15. Neural differentiation of induced pluripotent stem cells.
Denham M; Dottori M
Methods Mol Biol; 2011; 793():99-110. PubMed ID: 21913096
[TBL] [Abstract][Full Text] [Related]
16. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
De Pasquale V; Scerra G; Scarcella M; D'Agostino M; Pavone LM
Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
Perkins KJ; Muller V; Weber B; Hopwood JJ
Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
[TBL] [Abstract][Full Text] [Related]
18. Requirement for neurogenesis to proceed through the division of neuronal progenitors following differentiation of epidermal growth factor and fibroblast growth factor-2-responsive human neural stem cells.
Ostenfeld T; Svendsen CN
Stem Cells; 2004; 22(5):798-811. PubMed ID: 15342944
[TBL] [Abstract][Full Text] [Related]
19. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR
Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts.
Kan SH; Troitskaya LA; Sinow CS; Haitz K; Todd AK; Di Stefano A; Le SQ; Dickson PI; Tippin BL
Biochem J; 2014 Mar; 458(2):281-9. PubMed ID: 24266751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
